Pharmacological Breakthrough or Marketing Hype? Top Pharmacology News for March 2025
Medicine is on the verge of a new era, and pharmacology is its pulse. March 2025 was a month of big announcements, scientific breakthroughs, and ethical dilemmas. Here are the most important events that shook the pharmaceutical world.
1. Alzheimer’s gene therapy enters final phase of trials
The American company NeuroCore announced the successful completion of the third phase of clinical trials of gene therapy for patients with Alzheimer’s disease. The drug NC-β42 showed an improvement in cognitive functions in 62% of patients. It is expected that the application for registration will be submitted to the FDA in April. If approved, it will be the first such drug on the market.
2. Ukraine launches production of new mRNA-based vaccines
State-owned enterprise “Biopharma” has signed an agreement with a German concern to launch joint production of new-generation vaccines based on mRNA technologies. Production will start in June, with a focus on vaccines against influenza, HPV and hepatitis B. This is a strategic step towards pharmaceutical independence of Ukraine.
3. WHO warns: overprescribing antidepressants
The WHO’s annual report notes a rise in the number of patients being prescribed antidepressants without sufficient justification, especially among young people in Europe. The organization calls for the implementation of psychiatric screening protocols before prescribing psychotropic drugs. This has sparked a debate about the line between caring and the pharmacology of emotions.
4. Japan approves first CRISPR-based drug
Japan’s Ministry of Health has approved the world’s first drug developed using CRISPR-Cas9 technology, EditCellin, to treat a rare form of anemia, opening up new horizons for gene editing in therapeutic practice.
5. The herbal pharmacology market is growing
In March, analysts reported a 15% increase in investments in the development of herbal medicines. Curcumin, cannabinoids and ashwagandha are attracting particular attention. It is expected that new standardized preparations based on these substances will appear in 2025-2026.
What does this mean for us?
Pharmacology is changing rapidly: from molecules to microscopic scissors, from chemistry to bioengineering. But behind every pill is a question: does it really cure, or just calm fear? In March, we saw both hope and caution. It’s time not only to swallow, but also to ask questions.
